查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1426122

全球正子斷層掃描(PET)市場評估：按產品、偵測器、應用、最終用戶、地區、機會和預測（2017-2031年）

Positron Emission Tomography Market Assessment, By Product, By Detector, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 225 Pages | 商品交期: 3-5個工作天內

價格

全球正子斷層掃描 (PET) 市場規模將從 2023 年的 17 億美元增至 2031 年的 25.8 億美元，預計在 2024-2031 年預測期內複合年增長率為 5.1%。 市場受到心臟病、中風和癌症等慢性疾病增加的影響。 慢性病的快速增加增加了對 PET 掃描等先進診斷工具的需求，PET 掃描以其準確性和早期檢測能力而聞名。 另一個重要的驅動因素包括技術進步，例如解析度的提高和掃描速度的加快，這使得即使是複雜的手術也能進行精確成像，並最終提高診斷準確性和患者治療效果。 此外，混合 PET/CT 和 PET/MRI 系統的引入正在使 PET 掃描在臨床實踐中多樣化並提高其有效性，從而推動市場成長。

政府措施和資金也透過廣泛的研發 (R&D)、基礎設施擴張和報銷政策推動全球正子斷層掃描 (PET) 市場。 這些努力，加上業界不斷增加的投資和合作夥伴關係，正在推動創新並推動 PET 技術的發展。 此外，由於人口老化迅速增加，與年齡相關的疾病日益流行，增加了PET檢查的需求。 人們對 PET 影像的認識和接受度不斷提高，及其向神經病學和心臟病學等領域的擴展，進一步鞏固了其作為診斷工具的重要作用。

擴展PET掃描的應用

正子斷層掃描 (PET) 影像的應用範圍不斷擴大是市場擴張的主要驅動力。 最初，PET 影像因其在腫瘤診斷方面的優越性而被認可，但現在它已被應用於神經病學和心臟病學等多個醫學領域。 PET 技術的進步和新型放射性追蹤劑的開發不斷擴大 PET 的用途，使醫療保健專業人員能夠更深入地研究疾病機制、治療反應和個人化醫療方法。 應用的增加不僅提高了患者護理標準，而且增加了對 PET 成像系統的需求，為全球 PET 市場的滲透和持續增長做出了重大貢獻。 此外，最大限度地提高設備的靈敏度可以減少劑量並提供更快的診斷，從而擴展 PET 掃描在整個醫學領域的應用。

建立研究機構

新研究設施的建立是全球正子斷層掃描 (PET) 市場的主要驅動因素。 這些中心作為創新中心，促進尖端 PET 影像技術、放射性追蹤劑和方法的進步。 這些中心促進合作研究，支持各種醫學應用的研究，並幫助提高 PET 在診斷和追蹤各種疾病狀況方面的有效性。 除了吸引投資和研究合作外，這些努力還將加速 PET 技術的發展並增加其對醫療保健的影響。 這個過程刺激了市場擴張並確保診斷能力的持續進步。

例如，澳洲國家全身 PET 設施於 2023 年 12 月 12 日成立。 該設施將推動癌症研究、神經系統疾病、心血管疾病研究、藥物開發等方面的進展。 該設施的推出旨在透過最大限度地減少掃描時間和輻射暴露來徹底改變患者護理標準。

政府措施

世界各國政府正積極實施策略，以加速全球正子斷層掃描 (PET) 市場的發展。 這些策略包括資助研究、促進技術進步以及提高 PET 技術的可用性。 透過支持研究和開發，政府正在推動 PET 成像的發展，並促進先進成像系統和創新放射性示蹤劑的開發。 此外，改善報銷政策和醫療基礎設施的努力在促進 PET 掃描的採用方面發揮著重要作用。 這些廣泛的政府措施旨在加強 PET 市場，促進其擴張並加強其在現代診斷醫學中的重要作用。

本報告研究並分析了全球正子斷層掃描 (PET) 市場，提供市場規模和預測、市場動態、主要參與者現狀和前景等。

目錄

第 1 章研究方法

第 2 章專案範圍與定義

第 3 章全球正子斷層掃描（PET）市場展望

第 4 章執行摘要

第 5 章全球正子斷層掃描 (PET) 市場展望（2017-2031）

  • 市場規模與預測
    • 金額
    • 數量
  • 按產品
    • 設備
    • 平台/軟體
  • 透過探測器
    • 矽光電倍增管 (SiPM)
    • 數位光子計數器 (DPC)
    • 原矽酸櫓 (LSO)
    • 原矽酸釔釔 (LYSO)
    • 其他
  • 依用途
    • 緊張
    • 腫瘤
    • 心血管
    • 其他
  • 按最終用戶
    • 醫院
    • 診斷/影像診所
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 南美洲
    • 亞太地區
    • 中東/非洲
  • 市佔率：依公司劃分（2023 年）

第 6 章全球正子斷層掃描 (PET) 市場展望：按地區劃分（2017-2031 年）

  • 北美
    • 按產品
    • 透過探測器
    • 依用途
    • 按最終用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 南美洲
    • 巴西
    • 阿根廷
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第 7 章市場地圖（2023 年）

  • 按產品
  • 透過探測器
  • 依用途
  • 按最終用戶
  • 按地區

第 8 章宏觀環境與產業結構

  • 需求與供給分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 9 章市場動態

  • 生長促進因素
  • 生長抑制因素（問題、限制因素）

第 10 章監理架構與創新

  • 臨床試驗
  • 專利情況
  • 監理機關的核准
  • 創新/新技術

第 11 章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析（2023 年）
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家公司進入市場）
  • 專利分析（如果適用）

第 12 章價格分析

第 13 章案例研究

第 14 章主要公司展望

  • GE Healthcare
  • Fujifilm Holdings Corporation
  • Siemens Healthineers Corporation
  • Canon Medical Systems Corporation
  • Neusoft Corporation
  • Shimadzu Corporation
  • CMR Naviscan
  • Mediso Ltd.
  • Koninklijke Philips N.V.
  • Yangzhou Kindsway Biotech Co. Ltd.
  • Shanghai United Imaging Healthcare Co Ltd.
  • Positron Corporation

第 15 章策略建議

第 16 章關於我們公司，免責聲明

Product Code: MX10985

Global positron emission tomography market is projected to witness a CAGR of 5.1% during the forecast period 2024-2031, growing from USD 1.7 billion in 2023 to USD 2.58 billion in 2031. The global positron emission tomography market is being influenced by the increasing prevalence of chronic diseases such as heart diseases, stroke, and cancer. This surge in chronic diseases is increasing the demand for advanced diagnostic tools like PET scans, known for their precision and early detection capabilities. Another important driver include technological advancements, such as increased resolution and fast scanning abilities, which enable precise imaging for complicated procedures, ultimately enhancing diagnostic precision and patient outcomes. Moreover, the introduction of hybrid PET/CT and PET/MRI systems have diversified and enhanced the effectiveness of PET scans in clinical settings, thereby propelling the growth of global positron emission tomography market.

Government initiatives and funding are also driving the global positron emission tomography market through extensive research and development (R&D), expansion in infrastructure, and reimbursement policies. Combined with increased investments and partnerships within the industry, these efforts encourage innovation and propel PET technology's evolution. Additionally, a burgeoning elderly population is increasing the demand for PET scans as age-related ailments become more prevalent. Growing recognition and acceptance of PET imaging, along with its expansion into fields like neurology and cardiology, is further solidifying its pivotal role as a diagnostic tool.

Growing Application of PET Scans

The growing scope of positron emission tomography (PET) imaging applications significantly drives the market expansion. Initially recognized for its dominance in oncology diagnostics, PET imaging now spans diverse medical domains like neurology and cardiology. With the evolution of PET technology and the development of novel radiotracers, its utility continues to grow, empowering healthcare experts to delve deeper into disease mechanisms, treatment responses, and personalized medical approaches. This increased array of applications not only elevates patient care standards, but also increases the demand for PET imaging systems, thus significantly contributing to the widespread adoption and continuous growth of the global positron emission tomography market. In addition, the device's maximized sensitivity can be used to reduce the dosage and offer faster diagnosis, which will expand the application of PET scans across the healthcare domain.

Establishment of Research Facilities

The establishment of new research facilities is a key driving factor for the global positron emission tomography market. These centers act as innovation hubs, nurturing the advancement of cutting-edge PET imaging technologies, radiotracers, and methods. They facilitate joint research endeavors, support the exploration of various medical applications, and help improve PET's effectiveness in diagnosing and tracking different conditions. These initiatives not only draw investments and collaborations, but also expedite the development of PET technology, amplifying its influence on healthcare. This process stimulates market expansion and guarantees ongoing progress in diagnostic capabilities.

For example, the establishment of The Australian National Total Body PET Facility occurred on December 12th, 2023. Marking Australia's inaugural total body PET scanner available for unrestricted research use, this facility is poised to propel progress in cancer research, neurological disorders, cardiovascular disease studies, and pharmaceutical development. Its implementation aims to minimize scanning durations and radiation exposure, thereby revolutionizing patient care standards.

Government Initiatives

Governments around the globe are proactively implementing strategies to drive the advancement of the global positron emission tomography market. These strategies involve financing research, promoting technological progress, and improving the availability of PET technology. By supporting R&D, governments encourage the evolution of PET imaging, nurturing the development of advanced imaging systems and innovative radiotracers. Moreover, initiatives to improve reimbursement policies and healthcare infrastructure play a major role in driving the adoption of PET scan. These extensive government initiatives aim to strengthen the PET market, fostering its expansion and reinforcing its essential role in contemporary diagnostic medicine.

For instance, in November 2023, as a part of the Chief Minister's Comprehensive Health Insurance Scheme, Coimbatore Medical College Hospital (CMCH) received a boost with the commissioning of a PET CT (Positron emission tomography and computed tomography) scan machine worth INR 12 crore. At the CMCH, the procedure, which would have cost INR 20,000 in private hospitals, would only cost INR 6,500 to INR 11,000, with the Chief Minister's insurance plan covering the cost.

Increasing Use of PET Scan in Oncology

The use of PET in oncology is significantly driving the global market. PET imaging's accuracy in identifying and tracking cancerous developments supports early detection, precise staging, and evaluation of treatment response. Its capacity to offer comprehensive metabolic insights into tumors aids oncologists in making informed decisions. As PET technology advances persistently and new radiotracers emerge, its role in oncology is also growing. This progression not only enhances patient results, but also substantially bolsters the global adoption and growth of PET technology.

For instance, Meilleur Technologies, Inc. unveiled a research collaboration pact with the Young Blood Institute (YBI) on exploring the application of Meilleur's [F-18]NAV-4694, an investigative imaging agent, in positron emission tomography examinations. This device is designed to evaluate the presence of amyloid plaque within the brain. Amyloid plaques signify a prominent feature across various neurodegenerative conditions, notably Alzheimer's disease.

Advanced Software Solutions in Positron Emission Tomography

The increasing demand for PET software solutions is acting as a driving force behind the expansion of the global positron emission tomography market. With healthcare institutions progressively depending on PET imaging for precise disease diagnosis and monitoring treatments, there's a growing requirement for advanced software that improves image processing, analysis, and interpretation. Advanced PET software enhances workflow efficiency, facilitates precise data analysis, and improves the integration of PET scans with other imaging methods. This increased demand not only enhances the effectiveness of PET technology, but also contributes to market growth by meeting the changing demands of healthcare practitioners to deliver enhanced patient care.

For example, in May 2023, Precision DL (GE HealthCare), an AI-driven image processing software, received 510(k) clearance from the Food and Drug Administration (FDA). This software is anticipated to deliver notable enhancements in contrast-to-noise ratio (CNR), precision in quantifying features, and the ability to diagnose small lesions in PET scans.

Future Market Scenario (2024-2031F)

The future of the global positron emission tomography market exhibits remarkable promise, poised for substantial expansion. Various factors are contributing to this positive projection. Advancements in PET technology, encompassing enhanced imaging resolution, faster scan speeds, and the creation of novel radiotracers are expanding PET scan applications with increased accuracy. Furthermore, the surge in chronic diseases worldwide, alongside a growing elderly population, is increasing the demand for precise diagnostic tools like PET scans. Additionally, PET's diversified usage spanning beyond oncology into segments like neurology, cardiology, and psychiatric disorders solidifies its significance in healthcare diagnostics. Collaborative endeavors between public and private sectors, reinforced by supportive government measures and improved reimbursement policies, foster market growth. Besides this, ongoing research and technological advancements are expected to position the global positron emission tomography market for notable progress and evolution in the coming years.

Key Players Landscape and Outlook

Key global positron emission tomography market players are establishing strategic alliances. These partnerships among leading firms seek to combine resources, knowledge, and technologies, aiming to propel advancements in PET imaging. These collaborations focus on stimulating innovation, creating state-of-the-art PET systems, and pioneering new radiotracers. Such affiliations enable the integration of diverse strengths, fostering research and expediting the introduction of advanced PET solutions. Ultimately, these initiatives are driving the market's progression, ensuring refined diagnostic accuracy and substantially contributing to PET technology's global growth and progression.

In September 2023, Jubilant DraxImage Inc., operating as Jubilant Radiopharma, a wholly owned subsidiary of Jubilant Pharma Limited, initiated an exclusive collaboration with Cardiac Imaging, Inc. in Oakbrook Terrace, Illinois. The partnership aims to offer healthcare facilities a daily-leased rubidium solution for conducting cardiac PET scans, thereby enhancing access to cutting-edge cardiac PET imaging for patients suspected of coronary artery disease (CAD).

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Outlook of Global Positron Emission Tomography Market

4. Executive Summary

5. Global Positron Emission Tomography Market Outlook, 2017-2031F

  • 5.1. Market Size & Forecast
    • 5.1.1. Value
    • 5.1.2. Volume
  • 5.2. By Product
    • 5.2.1. Device
      • 5.2.1.1. Full Ring PET Scanners
      • 5.2.1.2. Partial Ring PET Scanners
    • 5.2.2. Platform/Software
  • 5.3. By Detector
    • 5.3.1. Silicon Photomultiplier (SiPM)
    • 5.3.2. Digital Photon Counters (DPC)
    • 5.3.3. Lutetium Oxyorthosilicate (LSO)
    • 5.3.4. Lutetium Yttrium Orthosilicate (LYSO)
    • 5.3.5. Others
  • 5.4. By Application
    • 5.4.1. Neurology
    • 5.4.2. Oncology
    • 5.4.3. Cardiovascular
    • 5.4.4. Others
  • 5.5. By End-user
    • 5.5.1. Hospitals
    • 5.5.2. Diagnostic & Imaging Clinics
    • 5.5.3. Others
  • 5.6. By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. South America
    • 5.6.4. Asia-Pacific
    • 5.6.5. Middle East and Africa
  • 5.7. By Company Market Share (%), 2023

6. Global Positron Emission Tomography Market Outlook, By Region, 2017-2031F

  • 6.1. North America*
    • 6.1.1. By Product
      • 6.1.1.1. Device
      • 6.1.1.1.1. Full Ring PET Scanners
      • 6.1.1.1.2. Partial Ring PET Scanners
      • 6.1.1.2. Platform/Software
    • 6.1.2. By Detector
      • 6.1.2.1. Silicon Photomultiplier (SiPM)
      • 6.1.2.2. Digital Photon Counters (DPC)
      • 6.1.2.3. Lutetium Oxyorthosilicate (LSO)
      • 6.1.2.4. Lutetium Yttrium Orthosilicate (LYSO)
      • 6.1.2.5. Others
    • 6.1.3. By Application
      • 6.1.3.1. Neurology
      • 6.1.3.2. Oncology
      • 6.1.3.3. Cardiovascular
      • 6.1.3.4. Others
    • 6.1.4. By End-user
      • 6.1.4.1. Hospitals
      • 6.1.4.2. Diagnostic & Imaging Clinics
      • 6.1.4.3. Others
    • 6.1.5. United States*
      • 6.1.5.1. By Product
      • 6.1.5.1.1. Device
      • 6.1.5.1.1.1. Full Ring PET Scanners
      • 6.1.5.1.1.2. Partial Ring PET Scanners
      • 6.1.5.1.2. Platform/Software
      • 6.1.5.2. By Detector
      • 6.1.5.2.1. Silicon Photomultiplier (SiPM)
      • 6.1.5.2.2. Digital Photon Counters (DPC)
      • 6.1.5.2.3. Lutetium Oxyorthosilicate (LSO)
      • 6.1.5.2.4. Lutetium Yttrium Orthosilicate (LYSO)
      • 6.1.5.2.5. Others
      • 6.1.5.3. By Application
      • 6.1.5.3.1. Neurology
      • 6.1.5.3.2. Oncology
      • 6.1.5.3.3. Cardiovascular
      • 6.1.5.3.4. Others
      • 6.1.5.4. By End-user
      • 6.1.5.4.1. Hospitals
      • 6.1.5.4.2. Diagnostic & Imaging Clinics
      • 6.1.5.4.3. Others
    • 6.1.6. Canada
    • 6.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 6.2. Europe
    • 6.2.1 Germany
    • 6.2.2 France
    • 6.2.3 Italy
    • 6.2.4 United Kingdom
    • 6.2.5 Russia
    • 6.2.6 Netherlands
    • 6.2.7 Spain
    • 6.2.8 Turkey
    • 6.2.9 Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
  • 6.4. Asia-Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2023

  • 7.1. By Product
  • 7.2. By Detector
  • 7.3. By Application
  • 7.4. By End-user
  • 7.5. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis
  • 8.3. Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges and Restraints)

10. Regulatory Framework and Innovation

  • 10.1 Clinical Trials
  • 10.2 Patent Landscape
  • 10.3 Regulatory Approvals
  • 10.4 Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. GE Healthcare
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Fujifilm Holdings Corporation
  • 14.3. Siemens Healthineers Corporation
  • 14.4. Canon Medical Systems Corporation
  • 14.5. Neusoft Corporation
  • 14.6. Shimadzu Corporation
  • 14.7. CMR Naviscan
  • 14.8. Mediso Ltd.
  • 14.9. Koninklijke Philips N.V.
  • 14.10. Yangzhou Kindsway Biotech Co. Ltd.
  • 14.11. Shanghai United Imaging Healthcare Co Ltd.
  • 14.12. Positron Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15. Strategic Recommendations

16. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 3. Global Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 5. Global Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Positron Emission Tomography Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 10. North America Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 11. North America Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 12. North America Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Positron Emission Tomography Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 17. United States Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 18. United States Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 19. United States Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 23. Canada Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 24. Canada Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 25. Canada Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 29. Mexico Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 30. Mexico Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 31. Mexico Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 35. Europe Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 36. Europe Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 37. Europe Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Positron Emission Tomography Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 42. Germany Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 43. Germany Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 44. Germany Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 48. France Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 49. France Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 50. France Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 51. France Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 54. Italy Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 55. Italy Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 56. Italy Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 60. United Kingdom Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 61. United Kingdom Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 62. United Kingdom Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 66. Russia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 67. Russia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 68. Russia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 72. Netherlands Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 73. Netherlands Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 74. Netherlands Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 78. Spain Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 79. Spain Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 80. Spain Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 84. Turkey Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 85. Turkey Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 86. Turkey Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 90. Poland Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 91. Poland Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 92. Poland Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 96. South America Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 97. South America Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 98. South America Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Positron Emission Tomography Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 103. Brazil Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 104. Brazil Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 105. Brazil Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 109. Argentina Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 110. Argentina Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 111. Argentina Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 115. Asia-Pacific Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 116. Asia-Pacific Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 117. Asia-Pacific Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Positron Emission Tomography Market Share (%), By Country, 2017-2031F
  • Figure 120. India Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 122. India Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 123. India Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 124. India Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 125. India Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 128. China Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 129. China Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 130. China Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 131. China Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 134. Japan Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 135. Japan Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 136. Japan Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 140. Australia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 141. Australia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 142. Australia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 146. Vietnam Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 147. Vietnam Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 148. Vietnam Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 152. South Korea Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 153. South Korea Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 154. South Korea Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 158. Indonesia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 159. Indonesia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 160. Indonesia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 164. Philippines Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 165. Philippines Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 166. Philippines Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 170. Middle East & Africa Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 171. Middle East & Africa Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 172. Middle East & Africa Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Positron Emission Tomography Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 177. Saudi Arabia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 178. Saudi Arabia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 179. Saudi Arabia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 183. UAE Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 184. UAE Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 185. UAE Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 189. South Africa Positron Emission Tomography Market Share (%), By Product, 2017-2031F
  • Figure 190. South Africa Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
  • Figure 191. South Africa Positron Emission Tomography Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Detector Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023